Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

Mostra altre versioni (2)

BACKGROUND: Daily aspirin reduces the long-term incidence of some adenocarcinomas, but effects on mortality due to some cancers appear after only a few years, suggesting that it might also reduce growth or metastasis. We established the frequency of distant metastasis in patients who developed cance...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Rothwell, P, Wilson, M, Price, J, Belch, J, Meade, T, Mehta, Z
Natura:	Journal article
Lingua:	English
Pubblicazione:	2012

Documenti analoghi

Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials
di: Rothwell, P, et al.
Pubblicazione: (2012)

Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials
di: Rothwell, P, et al.
Pubblicazione: (2012)

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.
di: Rothwell, P, et al.
Pubblicazione: (2012)

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials
di: Rothwell, P, et al.
Pubblicazione: (2012)

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials
di: Rothwell, P, et al.
Pubblicazione: (2012)

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.
di: Rothwell, P, et al.
Pubblicazione: (2011)

Effect of Daily Aspirin on Long-Term Risk of Death Due to Cancer: Analysis of Individual Patient Data From Randomized Trials
di: Rothwell, P, et al.
Pubblicazione: (2011)

Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
di: Rothwell, P, et al.
Pubblicazione: (2018)

Individual-patient meta-analysis: Daily aspirin reduces risk for incident cancer with distant metastasis
di: Rothwell, P
Pubblicazione: (2012)

Effects on colon cancer risk in randomised trials of aspirin
di: Rothwell, P
Pubblicazione: (2011)

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.
di: Rothwell, P, et al.
Pubblicazione: (2010)

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.
di: Algra, A, et al.
Pubblicazione: (2012)

Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic comparison of evidence from observational studies versus randomised trials
di: Algra, A, et al.
Pubblicazione: (2012)

Efficacy of aspirin in people with diabetes: an individual participant data meta-analysis of 26 randomised trials
di: Wong, C, et al.
Pubblicazione: (2014)

Randomised trial of prophylactic daily aspirin in British male doctors.
di: Weber, E
Pubblicazione: (1988)

Randomised trial of prophylactic daily aspirin in British male doctors.
di: Peto, R, et al.
Pubblicazione: (1988)

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
di: Flossmann, E, et al.
Pubblicazione: (2007)

Alternate-day, low-dose aspirin and cancer risk.
di: Rothwell, P
Pubblicazione: (2013)

Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
di: Rothwell, PM, et al.
Pubblicazione: (2016)

Aspirin in the prevention of cancer Reply
di: Rothwell, P
Pubblicazione: (2011)

Aspirin, salicylates and cancer
di: Morgan, G, et al.
Pubblicazione: (2011)

Aspirin in prevention of sporadic colorectal cancer: current clinical evidence and overall balance of risks and benefits.
di: Rothwell, P
Pubblicazione: (2013)

Potential biomarker for aspirin use in colorectal cancer therapy.
di: Langley, R, et al.
Pubblicazione: (2013)

Commentary: aspirin and colorectal cancer an epidemiological success story.
di: Flossmann, E, et al.
Pubblicazione: (2007)

Aspirin and endometrial cancer risk
di: Theodore M. Brasky, et al.
Pubblicazione: (2016-08-01)

Age-Specific Risk and Severity of Bleeding on Aspirin-based Secondary Prevention: A Population-Based Study
di: Geraghty, O, et al.
Pubblicazione: (2012)

Regular use of aspirin and pancreatic cancer risk
di: Mahoney Martin C, et al.
Pubblicazione: (2002-09-01)

Biological markers: Potential biomarker for aspirin use in colorectal cancer therapy
di: Langley, R, et al.
Pubblicazione: (2013)

Regular aspirin use and lung cancer risk
di: Cummings K, et al.
Pubblicazione: (2002-11-01)

Daily Antiplatelets Other Than Aspirin Reduce Liver Cancer Risk but Increase Intracranial Hemorrhage Risk in Cirrhotic Patients
di: Lee CH, et al.
Pubblicazione: (2024-10-01)

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
di: Baigent, C, et al.
Pubblicazione: (2009)

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
di: Gaziano, J, et al.
Pubblicazione: (2018)

Aspirin as secondary prevention in colorectal cancer liver metastasis (ASAC trial): study protocol for a multicentre randomized placebo-controlled trial
di: Sheraz Yaqub, et al.
Pubblicazione: (2021-09-01)

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
di: Jankowski, J, et al.
Pubblicazione: (2018)

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
di: Jankowski, J, et al.
Pubblicazione: (2018)

ECPPA: Randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women
di: Atallah, A, et al.
Pubblicazione: (1996)

CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke
di: Chen, Z, et al.
Pubblicazione: (1997)

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
di: Chen, Z, et al.
Pubblicazione: (2005)

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
di: Bousser, MG, et al.
Pubblicazione: (2011)

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): A randomised, double-blind, parallel-group trial
di: Bousser, M, et al.
Pubblicazione: (2011)